Ricardo M. Attar

4.9k citations

72 papers · 3.2k indexed · h-index 30

Endocrinology, Diabetes and Metabolism top 1%
- Growth Hormone and Insulin-like Growth Factors 17
- Hormonal and reproductive studies 11
Cancer Research top 2%
Oncology top 5%
- CAR-T cell therapy research 7
Pulmonary and Respiratory Medicine top 5%
- Prostate Cancer Treatment and Research 9
Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 9
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 17
Genetics
- Estrogen and related hormone effects 10
Hematology
- Multiple Myeloma Research and Treatments 8

Co-authors: Marco M. Gottardis Joan M. Carboni Chris H. Takimoto Mark Salvati Roberto Weinmann Michael Gilman Stanley R. Krystek John S. Sack
Cited by: Endocrinology, Diabetes and Metabolism Cancer Research Oncology
Journals: Proceedings of the National Academy of Sciences (2 papers)Nucleic Acids Research (1 paper)Journal of Biological Chemistry (2 papers)
Partner nations: United States Germany Belgium

In The Last Decade

Ricardo M. Attar

72 papers receiving 3.1k citations

Peers

Countries citing papers authored by Ricardo M. Attar

Since Specialization

Citations

This map shows the geographic impact of Ricardo M. Attar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo M. Attar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo M. Attar more than expected).

Fields of papers citing papers by Ricardo M. Attar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo M. Attar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo M. Attar. The network helps show where Ricardo M. Attar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ricardo M. Attar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ricardo M. Attar Line = papers co-authored together Ricardo M. Attar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models Blood ·Kodandaram Pillarisetti,Danlin Yang,Leopoldo Luistro,Jianhong Yao,Melissa Smith,Peter Vulfson,James Testa,Randolph Ponticiello,Scott R. Brodeur,Bradley Heidrich,Kathryn Packman,Sanjaya Singh,Ricardo M. Attar,Yusri Elsayed,Ulrike Philippar	2025	3
2	A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors Cancer Research ·Sheri L. Moores,Mark L. Chiu,Barbara S. Bushey,Kristen Chevalier,Leopoldo Luistro,Keri Dorn,Randall J. Brezski,Peter Haytko,Thomas J. Kelly,Sheng‐Jiun Wu,Pauline L. Martin,Joost Neijssen,Paul W.H.I. Parren,Janine Schuurman,Ricardo M. Attar,Sylvie Laquerre,Matthew V. Lorenzi,Geoffrey M. Anderson	2016	188
3	Drug safety is a barrier to the discovery and development of new androgen receptor antagonists The Prostate ·William R. Foster,Bruce D. Car,Hong Shi,Paul Lévesque,Mary T. Obermeier,Jinping Gan,Joseph C. Arezzo,Stephanie S. Powlin,Joseph Dinchuk,Aaron Balog,Mark Salvati,Ricardo M. Attar,Marco M. Gottardis	2010	92
4	Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro Cancer Research ·Andrea E. Wahner Hendrickson,Paul Haluska,Paula A. Schneider,David A. Loegering,Kevin Peterson,Ricardo M. Attar,B. Douglas Smith,Charles Erlichman,Marco M. Gottardis,Judith E. Karp,Joan M. Carboni,Scott H. Kaufmann	2009	43
5	Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer Cancer Research ·Ricardo M. Attar,Maria Jure–Kunkel,Aaron Balog,Mary Ellen Cvijic,Janet Dell-John,Cheryl A. Rizzo,Liang Schweizer,Thomas Spires,J. Suso Platero,Mary T. Obermeier,Weifang Shan,Mark Salvati,William R. Foster,Joseph Dinchuk,Shen-Jue Chen,Gregory D. Vite,Robert A. Kramer,Marco M. Gottardis	2009	38
6	BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR Molecular Cancer Therapeutics ·Joan M. Carboni,Mark D. Wittman,Zheng Yang,Francis Lee,Ann Greer,Warren Hurlburt,Stephen Hillerman,Carolyn Cao,Glenn H. Cantor,Janet Dell-John,Cliff Chen,Lorell Discenza,Krista Menard,Aixin Li,George L. Trainor,Dolatrai M. Vyas,Robert A. Kramer,Ricardo M. Attar,Marco M. Gottardis	2009	218
7	BMS-536924 Reverses IGF-IR-Induced Transformation of Mammary Epithelial Cells and Causes Growth Inhibition and Polarization of MCF7 Cells Clinical Cancer Research ·Beate C. Litzenburger,Hyun-Jung Kim,Isere Kuiatse,Joan M. Carboni,Ricardo M. Attar,Marco M. Gottardis,Craig R. Fairchild,Adrian V. Lee	2008	33
8	The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors Cancer Research ·Fei Huang,Ann Greer,Warren Hurlburt,Xia Han,Rameh Hafezi,Gayle Wittenberg,Karen A. Reeves,Jiwen Chen,Douglas Robinson,Aixin Li,Francis Y. Lee,Marco M. Gottardis,Edwin Clark,Lee J. Helman,Ricardo M. Attar,Ashok Dongre,Joan M. Carboni	2008	137
9	Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors Molecular Cancer Therapeutics ·Petra Ross‐Macdonald,Heshani de Silva,Qi Guo,Hong Xiao,Chen-Yi Hung,Becky Penhallow,Jay A. Markwalder,Liqi He,Ricardo M. Attar,Tai-An Lin,Steven P. Seitz,Charles Tilford,Judith Wardwell-Swanson,Donald Jackson	2008	102
10	2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 Bioorganic & Medicinal Chemistry Letters ·Mark G. Saulnier,David B. Frennesson,Mark D. Wittman,Kurt Zimmermann,Upender Velaparthi,David R. Langley,Charles Struzynski,Xiaopeng Sang,Joan M. Carboni,Aixin Li,Ann Greer,Zheng Yang,Praveen Balimane,Marco M. Gottardis,Ricardo M. Attar,Dolatrai M. Vyas	2008	20
11	Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Mark Salvati,Aaron Balog,Weifang Shan,Richard Rampulla,Soren Giese,Tom Mitt,Joseph A. Furch,Gregory D. Vite,Ricardo M. Attar,Maria Jure–Kunkel,Jieping Geng,Cheryl A. Rizzo,Marco M. Gottardis,Stanley R. Krystek,Jack Z. Gougoutas,Michael A. Galella,Mary T. Obermeier,Aberra Fura,Gamini Chandrasena	2008	20
12	Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors Bioorganic & Medicinal Chemistry Letters ·Kurt Zimmermann,Mark D. Wittman,Mark G. Saulnier,Upender Velaparthi,David R. Langley,Xiaopeng Sang,David B. Frennesson,Joan M. Carboni,Aixin Li,Ann Greer,Marco M. Gottardis,Ricardo M. Attar,Zheng Yang,Praveen Balimane,Lorell Discenza,Dolatrai M. Vyas	2008	17
13	Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail Molecular and Cellular Biology ·Hyun Jung Kim,Beate C. Litzenburger,Xiaojiang Cui,David A. Delgado,Brian C. Grabiner,Xin Lin,Michael T. Lewis,Marco M. Gottardis,Tai W. Wong,Ricardo M. Attar,Joan M. Carboni,Adrian V. Lee	2007	196
14	Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase Bioorganic & Medicinal Chemistry Letters ·Mark D. Wittman,Balu Balasubramanian,Karen M. Stoffan,Upender Velaparthi,Pieying Liu,Subramaniam Krishnanathan,Joan M. Carboni,Aixin Li,Ann Greer,Ricardo M. Attar,Marco M. Gottardis,ChiehYing Y. Chang,Bruce L. Jacobson,Yax Sun,Steven Hansel,Mary Zoeckler,Dolatrai M. Vyas	2006	19
15	BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in cancer cell lines Cancer Research ·Paul Haluska,Joan M. Carboni,David A. Loegering,Francis Y. Lee,Mark G. Saulnier,David B. Frennesson,Ricardo M. Attar,Kimberly R. Kalli,Cheryl A. Conover,Sumithra J. Mandrekar,Scott H. Kaufmann,Marco M. Gottardis,Charles Erlichman	2005	2
16	Identification of novel functional inhibitors of 17β-hydroxysteroid dehydrogenase type III (17β-HSD3) The Prostate ·Thomas Spires,Brian E. Fink,Ellen K. Kick,Dan You,Cheryl A. Rizzo,Ivone M. Takenaka,R. Michael Lawrence,Zheming Ruan,Mark Salvati,Gregory D. Vite,Roberto Weinmann,Ricardo M. Attar,Marco M. Gottardis,Matthew V. Lorenzi	2005	22
17	The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Aaron Balog,Mark Salvati,Weifang Shan,Arvind Mathur,Leslie Leith,Donna Wei,Ricardo M. Attar,Jieping Geng,Cheryl A. Rizzo,Chihuei Wang,Stanley R. Krystek,John S. Tokarski,John T. Hunt,Marco M. Gottardis,Roberto Weinmann	2004	25
18	Expression of Constitutively Active IκBβ in T Cells of Transgenic Mice: Persistent NF-κB Activity Is Required for T-Cell Immune Responses Molecular and Cellular Biology ·Ricardo M. Attar,Heather Macdonald-Bravo,Carmen Raventós-Suárez,Stephen K. Durham,Rodrigo Bravo	1998	48
19	A Conditionally Expressed Third Partner Stabilizes or Prevents the Formation of a Transcriptional Activator in a Three-hybrid System Journal of Biological Chemistry ·Franck Tirode,Claudia Malaguti,Francisco Romero,Ricardo M. Attar,Jacques Camonis,Jean‐Marc Egly	1997	92
20	A cycloheximide-inducible gene ofNeurospora crassabelongs to the cytochrome P-450 superfamily Nucleic Acids Research ·Ricardo M. Attar,Erich Grotewold,Guillermo E. Taccioli,Gabriel O. Aisemberg,Héctor N. Torres,Norberto D. Judewicz	1989	14

About Ricardo M. Attar

Ricardo M. Attar is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 72 papers that have together received 3.2k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (17 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Hormonal and reproductive studies (11 papers), Estrogen and related hormone effects (10 papers), Metabolism, Diabetes, and Cancer (9 papers), Prostate Cancer Treatment and Research (9 papers), Multiple Myeloma Research and Treatments (8 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (864 citations), Cancer Research (652 citations) and Oncology (877 citations). Ricardo M. Attar has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Marco M. Gottardis, Joan M. Carboni, Chris H. Takimoto, Mark Salvati, Roberto Weinmann, Michael Gilman, Stanley R. Krystek, John S. Sack, Chihuei Wang and Kevin Kish. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact